Xenon Pharmaceuticals XENE
NASDAQ XENE
$40.97 -0.42 (-1.03%)
As of: Nov 11, 2026 · 10:31 AM EST

Xenon Pharmaceuticals (XENE) Long-Term Debt Issuances (2018)

Updated

Xenon Pharmaceuticals (XENE) posted Long-Term Debt Issuances of $8.45 million for FY2018, up 22.6% from $6.89 million in FY2017.

Analysis

Xenon Pharmaceuticals (XENE) Long-Term Debt Issuances (2018) Analysis & Trends

  • Business Quant data shows XENE's Long-Term Debt Issuances at $6.89 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Xenon Pharmaceuticals 4.07 Bn 542.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 3.46 Mn
API Access

Xenon Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=XENE&period=max&api_key=YOUR_API_KEY